About Us
Our Story
Rooted in the pharmacy industry. Built for impact.
ARx Ventures was founded on a simple but powerful belief: pharmacy owners deserve more clarity, support, and value when it comes to selling or growing their business. We saw too many advisors offering general solutions without truly understanding the operational realities or emotional weight that come with running a pharmacy.
That’s where we’re different.
What began as a boutique M&A advisory with deep ties to the pharmaceutical and healthcare sectors has quickly become a trusted partner to pharmacy owners and investors across Canada. We’ve advised on more than $40M in transaction value and helped clients unlock over $6M in EBITDA improvements.
Whether you’re ready to exit or just exploring options, we’re here to guide you, one step at a time.
Total transaction value advised
$40M+
EBITDA improvements unlocked for clients
$6M+
8+ Years
Industry experience across healthcare
Pharmacy owners and operators advised
100+
Meet Our Founder - Arik Liberman
Arik Liberman, Founder and CEO of ARx Ventures
With nearly a decade of experience at the intersection of healthcare, operations, and M&A, Arik founded ARx Ventures to create a better path forward for pharmacy owners.
Arik has led large-scale acquisitions, optimized health operations, and advised executives at companies like SRx Health Solutions, CloudMD, and Trindent Consulting. He’s overseen projects spanning due diligence, financial modeling, pharmacy performance, and post-acquisition integration with a sharp eye for process and a deep respect for people.
Arik holds a Master of Science from McMaster University and a Bachelor’s degree in Kinesiology from Western University. Beyond his credentials, what defines him is his passion for solving problems, building long-term relationships, and making complex transitions simple for business owners.
“This is about more than closing a deal — it’s about making sure pharmacy owners walk away confident, informed, and valued.”
Meet the Team
-
Kaiden Kane
Director of Acquisitions
-
Chase Mulligan
M&A Analyst
-
Noah Goguen
M&A Analyst
Our Team
We are a specialized group of professionals integrating operational depth with high-level transactional expertise. Our structure is intentionally lean, ensuring that every client receives direct, senior-level attention without the friction of a large-firm hierarchy.
Operational Precision
Our operations leadership understands the granular realities of the pharmacy—from workflow optimization and compliance pressures to patient dynamics. This ensures that every deal is grounded in the actual value of the business, not just the numbers on a page.
M&A Execution
Our core M&A team manages the full deal lifecycle. We bring rigorous financial analysis and hands-on experience in both buy-side and sell-side mandates. From initial valuation and targeted outreach to complex negotiations and closing, we provide the technical sophistication required to navigate high-stakes exits and acquisitions.
Strategic Support
We leverage a network of specialized advisors to provide insights into legal, tax, and succession planning. This allows us to scale our expertise based on the unique requirements of the transaction, providing comprehensive support without unnecessary overhead.
Capital & Vision
Our investors provide more than liquidity; they provide a long-term strategic backbone. Their backing allows ARx Ventures to remain independent and agile, moving with the speed necessary to capture market opportunities while staying focused exclusively on the objectives of founders and buyers.
Key Values
Clarity Over Complexity
We communicate clearly, set expectations early, and make every step as simple as possible.
Trust First
We treat every client like a long-term partner and always act with integrity.
Execution that matters
We get things done thoroughly, thoughtfully, and on your timeline.